• Home
  • News
  • Parliamentary inquiry into allergy and anaphylaxis

Parliamentary inquiry into allergy and anaphylaxis

19 November 2019

The National Allergy Strategy was pleased to be invited to speak at the public hearing of the parliamentary inquiry into allergy and anaphylaxis, in Sydney on the 19th November 2019. ASCIA and Allergy & Anaphylaxis Australia were also invited to speak at the hearing. 

We would once again, like to acknowledge Mr Trent Zimmerman and Minister Hunt for their support of Australians living with allergic diseases by conducting this inquiry.

Parliamentary inquiry into allergy and anaphylaxis

Pictured from: left Dr Preeti Joshi, Ms Karen Wong (back) Ms Maria Said, Mr Trent Zimmerman, Dr Mike Freelander, Ms Sandra Vale, Dr Brynn Wainstein, Ms Jody Aiken and Ms Jill Smith  


Content created November 2019





National Allergy Strategy Rationale

Allergic diseases have become an increasingly important chronic disease and public health issue in Australia and other developed countries over the last two decades, contributing to increased demand for medical services, significant economic cost of care and reduced quality of life of people with allergic diseases and their carers.

Information Partner

trusted health information
Funded by the governments of Australia

Lead organisations

ascia logo 2018s
Australasian Society of Clinical Immunology and Allergy (ASCIA) is the leading medical organisation for allergy in Australia. 

aaa logo 2018s
Allergy & Anaphylaxis Australia (A&AA) is the leading patient support organisation for allergy in Australia. 

The National Allergy Strategy has received funding from the Australian Government Department of Health for the following projects:
Food allergy prevention | 250K Youth Project | Food service | Drug allergy | Shared Care Model

© National Allergy Strategy Aug 2015 | Contact Us | Disclaimer | Food Allergy Training Help | Privacy | Sitemap